Effect of fluvoxamine and combination with sorafenib on the proliferation of hepatocellular cancer HepG2 Cells

dc.authoridAktas, Ranan/0000-0002-4474-7371en_US
dc.authoridÖzünal, Zeynep güneş/0000-0002-3060-1507en_US
dc.contributor.authorÖzünal, Zeynep G.
dc.contributor.authorÇakıl, Y. Dönmez
dc.contributor.authorIsan, H.
dc.contributor.authorSaglam, E.
dc.contributor.authorAktas, R. G.
dc.date.accessioned2024-07-12T21:40:33Z
dc.date.available2024-07-12T21:40:33Z
dc.date.issued2019en_US
dc.department[Belirlenecek]en_US
dc.description32nd Congress of the European-College-of-Neuropsychopharmacology (ECNP) -- SEP 07-10, 2019 -- Copenhagen, DENMARKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Coll Neuropsychopharmacolen_US
dc.description.sponsorshipMaltepe University Research Project Councilen_US
dc.description.sponsorshipThis research is funded by Maltepe University Research Project Council.en_US
dc.identifier.doi10.1016/j.euroneuro.2019.09.792
dc.identifier.endpageS509en_US
dc.identifier.issn0924-977X
dc.identifier.issn1873-7862
dc.identifier.startpageS509en_US
dc.identifier.urihttps://doi.org/10.1016/j.euroneuro.2019.09.792
dc.identifier.urihttps://hdl.handle.net/20.500.12415/7362
dc.identifier.volume29en_US
dc.identifier.wosWOS:000502657504119en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofEuropean Neuropsychopharmacologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY08703
dc.titleEffect of fluvoxamine and combination with sorafenib on the proliferation of hepatocellular cancer HepG2 Cellsen_US
dc.typeConference Object
dspace.entity.typePublication

Dosyalar